| Literature DB >> 25488702 |
Dariusz Wyrzykowski1, Anna Kloska, Joanna Pranczk, Aneta Szczepańska, Aleksandra Tesmar, Dagmara Jacewicz, Bogusław Pilarski, Lech Chmurzyński.
Abstract
The potentiometric and conductometric titration methods have been used to characterize the stability of series ofEntities:
Mesh:
Substances:
Year: 2014 PMID: 25488702 PMCID: PMC4352194 DOI: 10.1007/s12011-014-0170-x
Source DB: PubMed Journal: Biol Trace Elem Res ISSN: 0163-4984 Impact factor: 3.738
The relative permittivity ε, density σ and viscosity η for DMSO-water mixtures at 298.15 K
| DMSO ( |
|
|
|
|---|---|---|---|
| 1 | 78.36 | 0.997 | 0.89 |
| 10 | 77.75 | 1.011 | 1.07 |
| 20 | 76.96 | 1.026 | 1.38 |
| 30 | 76.21 | 1.042 | 1.79 |
| 40 | 75.45 | 1.057 | 2.35 |
| 50 | 74.70 | 1.072 | 3.00 |
Logarithms of the stability constants (logβ pqrs) of binary complexes of VO(IV), Co(II) and Ni(II) with oxydiacetate ion (ODA) obtained by adapting the equilibrium model to PT data
| No. | Species | log | M = Co2+ | M = Ni2+ | M = VO2+ |
|---|---|---|---|---|---|
| 1 | LH2 | log | 7.26 (±0.06) | 6.97 (±0.01) | 7.25 (±0.05) |
| 2 | LH | log | 4.16 (±0.09) | 4.12 (±0.01) | 4.20 (±0.05) |
| 3 | ML | log | 3.45 (±0.11) | 3.52 (±0.02) | 5.08 (±0.04) |
| 4 | MLH−2 | log | −14.88 (±0.14) | −14.17 (±0.06) | −6.45 (±0.04) |
| 5 | M2L2H−2 | log | – | – | 1.65 (±0.15) |
The standard deviations are given in parenthesis
Fig. 1Concentration distribution curves of the complexes as a function of pH (M:L = 1:1) calculated based on the stability constants listed in Table 2
Fig. 2pH-metric titration curves of H2ODA at 298.15 K in a water, b DMSO-water 30 % (v/v), c DMSO-water 50 % (v/v) binary system
The dissociation constants of oxydiacetate acid (expressed as pK a1 and pK a2) of different DMSO-water mixtures at 298.15 K
| DMSO(% | p | p | p |
|---|---|---|---|
| 0 | 2.90 (±0.05) | 4.28 (±0.08) | 14.0 |
| 10 | 3.11 (±0.04) | 4.52 (±0.02) | 14.09 |
| 20 | 3.28 (±0.02) | 4.69 (±0.02) | 14.26 |
| 30 | 3.42 (±0.04) | 4.91 (±0.02) | 14.40 |
| 40 | 3.61 (±0.03) | 5.16 (±0.02) | 14.66 |
| 50 | 3.76 (±0.03) | 5.46 (±0.03) | 14.82 |
The standard deviations are given in parenthesis
The limiting molar conductance (Λo) values in S cm2 mol−1 and the association constants (logK ass) of the oxydiacetate cobalt(II) and nickel(II) complexes in DMSO-water mixtures at 298.15 K
| Method | Parameter | DMSO-water (% | |||||
|---|---|---|---|---|---|---|---|
| 0 | 10 | 20 | 30 | 40 | 50 | ||
| NiODA | |||||||
| Shedlovsky | Λo | 216.10(±0.74) | 161.00(±0.95) | 119.83(±0.83) | 90.63(±1.37) | 51.85(±0.61) | 28.80(±0.48) |
|
| 3.33 (±0.01) | 3.47 (±0.01) | 3.59 (±0.01) | 3.74 (±0.01) | 4.05 (±0.02) | 4.15 (±0.03) | |
| Pitts | Λo | 216.74(±1.08) | 161.75(±0.93) | 114.72(±1.55) | 91.35(±1.33) | 52.00(±0.50) | 29.49(±0.92) |
|
| 3.34 (±0.01) | 3.48 (±0.01) | 3.56 (±0.01) | 3.75 (±0.01) | 4.05 (±0.01) | 4.17 (±0.04) | |
| CoODA | |||||||
| Shedlovsky | Λo | 223.49(±1.45) | 171.55(±0.74) | 133.47(±1.00) | 92.16(±1.07) | 55.24(±0.84) | 28.52(±1.58) |
|
| 3.35 (±0.01) | 3.49 (±0.01) | 3.77 (±0.01) | 3.89 (±0.01) | 4.09 (±0.03) | 4.22 (±0.02) | |
| Pitts | Λo | 226.58(±1.32) | 173.97(±0.60) | 134.29(±1.09) | 92.53(±0.96) | 57.02(±0.71) | 29.74(±1.46) |
|
| 3.38 (±0.01) | 3.51 (±0.01) | 3.77 (±0.01) | 3.89 (±0.01) | 4.05 (±0.01) | 4.32 (±0.03) | |
Fig. 3The superoxide free radicals scavenging activity of the complexes
The cytotoxic activity of VO(ODA), Co(ODA) and Ni(ODA) against the HDFa cell line expressed as the lethal concentration (LC) values (μM) after 24 h and 48 h of incubation (MTT test)
| NiODA | CoODA | VOODA | |
|---|---|---|---|
| 24-h exposure time | |||
| LC25 [μM] | Immeasurable | Immeasurable | 108.03 |
| LC50 [μM] | Immeasurable | Immeasurable | 295.74 |
| LC75 [μM] | Immeasurable | Immeasurable | 560.17 |
| 48-h exposure time | |||
| LC25 [μM] | 492.04 | Immeasurable | 27.03 |
| LC50 [μM] | 1309.71 | Immeasurable | 87.45 |
| LC75 [μM] | 2339.01 | Immeasurable | 180.53 |
LC values (μM) were estimated from dose–response curves using four-parameter logistic equations
Fig. 4The influence of VO(ODA), Ni(ODA) and Co(ODA) on the relative proliferation of HDFa cells after 6 days of exposure to investigated complex compounds (based on 24-h BrdU incorporation by actively dividing cells). Values represent means of four different experiments (run in duplicate) ± SD
The antiproliferative activity of the VO(ODA), Ni(ODA) and Co(ODA) complexes against HDFa cells after 6 days of exposure to investigated complex compounds (based on the 24-h BrdU incorporation by actively dividing cells)
| 6 day-exposure time | |||
|---|---|---|---|
| Ni(ODA) | Co(ODA) | VO(ODA) | |
| IC25 (μM) | 148.65 | 128.90 | 23.41 |
| IC50 (μM) | 219.97 | 175.08 | 24.86 |
| IC75 (μM) | >1000 | >1000 | 26.42 |
IC values (μM) were estimated from dose–response curves using four-parameter logistic equations
Fig. 5The viability of the HDFa cells after a 1-h incubation in the presence of 1 mM H2O2 and different concentrations of investigated complex compounds. K denotes cells not treated with H2O2 nor complexes (control cells). Values represent means of three different experiments (run in triplicate) ± SD
Fig. 6The viability of HDFa cells after an additional 48-h incubation in the growth medium following a 1-h incubation in the presence of 1 mM H2O2 and different concentrations of investigated complex compounds. K denotes cells not treated with H2O2 nor complexes (control cells). Values represent means of three different experiments (run in triplicate) ± SD
MIC and MBC values (μg/mL) for the complexes obtained in the broth dilution test
| Bacteria | Ni(ODA) (μg/mL) | Co(ODA) (μg/mL) | VO(ODA) (μg/mL) | |||
|---|---|---|---|---|---|---|
| MIC | MBC | MIC | MBC | MIC | MBC | |
|
| 512 | – | 256 | – | 2048 | – |
|
| 1024 | – | 512 | 1024 | 2048 | – |
|
| 1024 | – | 256 | – | 1024 | 1024 |
|
| 1024 | – | 256 | – | 1024 | – |
|
| 1024 | – | 256 | 512 | 1024 | 2048 |
|
| 512 | 2048 | 256 | 2048 | 2048 | 2048 |
Zones of complete bacterial growth inhibition (mm) for complexes obtained in the disc diffusion test
| Bacteria | Zone of growth inhibition (mm) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ni(ODA) | Co(ODA) | VO(ODA) | Neo | |||||||
| (μg/disc) | ||||||||||
| 100 | 500 | 1000 | 100 | 500 | 1000 | 100 | 500 | 1000 | 100 | |
|
| – | 8 | 8 | – | 9 | 11 | – | – | 7 | 21 |
|
| – | – | – | – | 12 | 14 | – | – | – | 15 |
|
| – | – | – | – | 10 | 15 | – | 9 | 13 | 16 |
|
| – | – | – | – | 14 | 18 | – | – | – | 17 |
|
| – | 7 | 8 | 7 | 12 | 17 | – | – | – | 18 |
|
| – | – | – | 8 | 19 | 23 | – | – | 12 | 25 |
Neomycin (Neo) was used as a control